These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 1972802)

  • 1. Antiepileptic drugs in the treatment of neuroleptic-induced supersensitivity psychosis.
    Sultan S; Chouinard G; Beaudry P
    Prog Neuropsychopharmacol Biol Psychiatry; 1990; 14(3):431-8. PubMed ID: 1972802
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risperidone and clozapine in the treatment of drug-resistant schizophrenia and neuroleptic-induced supersensitivity psychosis.
    Chouinard G; Vainer JL; Bélanger MC; Turnier L; Beaudry P; Roy JY; Miller R
    Prog Neuropsychopharmacol Biol Psychiatry; 1994 Nov; 18(7):1129-41. PubMed ID: 7531355
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of supersensitivity psychosis with antiepileptic drugs: report of a series of 43 cases.
    Chouinard G; Sultan S
    Psychopharmacol Bull; 1990; 26(3):337-41. PubMed ID: 2274634
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Severe cases of neuroleptic-induced supersensitivity psychosis. Diagnostic criteria for the disorder and its treatment.
    Chouinard G
    Schizophr Res; 1991; 5(1):21-33. PubMed ID: 1677263
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of clozapine on dopamine supersensitivity psychosis in schizophrenia.
    Nakata Y; Kanahara N; Kimura H; Watanabe H; Iyo M
    Int Clin Psychopharmacol; 2017 May; 32(3):169-173. PubMed ID: 28067751
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Supersensitivity psychosis and tardive dyskinesia: a survey in schizophrenic outpatients.
    Chouinard G; Annable L; Ross-Chouinard A
    Psychopharmacol Bull; 1986; 22(3):891-6. PubMed ID: 2879310
    [No Abstract]   [Full Text] [Related]  

  • 7. Neuroleptic-induced supersensitivity psychosis: clinical and pharmacologic characteristics.
    Chouinard G; Jones BD
    Am J Psychiatry; 1980 Jan; 137(1):16-21. PubMed ID: 6101522
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Neuroleptic withdrawal in patients meeting criteria for supersensitivity psychosis.
    Singh H; Hunt JI; Vitiello B; Simpson GM
    J Clin Psychiatry; 1990 Aug; 51(8):319-21. PubMed ID: 1974249
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Basic and clinical studies of neuroleptic-induced supersensitivity psychosis and dyskinesia.
    Diamond BI; Borison RL
    Psychopharmacol Bull; 1986; 22(3):900-5. PubMed ID: 2879312
    [No Abstract]   [Full Text] [Related]  

  • 10. Dopamine supersensitivity psychosis in schizophrenia: Concepts and implications in clinical practice.
    Nakata Y; Kanahara N; Iyo M
    J Psychopharmacol; 2017 Dec; 31(12):1511-1518. PubMed ID: 28925317
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Neuroleptic-induced supersensitivity psychosis in patients with bipolar affective disorder.
    Steiner W; Laporta M; Chouinard G
    Acta Psychiatr Scand; 1990 May; 81(5):437-40. PubMed ID: 1972608
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The concept of supersensitivity psychosis.
    Kirkpatrick B; Alphs L; Buchanan RW
    J Nerv Ment Dis; 1992 Apr; 180(4):265-70. PubMed ID: 1348269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Carbamazepine adjunct for nonresponsive psychosis with prior hallucinogenic abuse.
    Scher M; Neppe V
    J Nerv Ment Dis; 1989 Dec; 177(12):755-7. PubMed ID: 2574229
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Risperidone long-acting injectable in the treatment of treatment-resistant schizophrenia with dopamine supersensitivity psychosis: Results of a 2-year prospective study, including an additional 1-year follow-up.
    Kimura H; Kanahara N; Sasaki T; Komatsu N; Ishige M; Muneoka K; Ino H; Yoshimura K; Yamanaka H; Suzuki T; Komatsu H; Watanabe H; Shimizu E; Iyo M
    J Psychopharmacol; 2016 Aug; 30(8):795-802. PubMed ID: 27371496
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Loss of striatal cholinergic neurons as a basis for tardive and L-dopa-induced dyskinesias, neuroleptic-induced supersensitivity psychosis and refractory schizophrenia.
    Miller R; Chouinard G
    Biol Psychiatry; 1993 Nov; 34(10):713-38. PubMed ID: 7904833
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dopamine supersensitivity psychosis as a pivotal factor in treatment-resistant schizophrenia.
    Suzuki T; Kanahara N; Yamanaka H; Takase M; Kimura H; Watanabe H; Iyo M
    Psychiatry Res; 2015 Jun; 227(2-3):278-82. PubMed ID: 25863824
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Use of carbamazepine in psychosis after neuroleptic malignant syndrome.
    Peet M; Collier J
    Br J Psychiatry; 1990 Apr; 156():579-81. PubMed ID: 2386874
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuroleptic-induced supersensitivity psychosis: retrospective study of schizophrenic inpatients.
    Hunt JI; Singh H; Simpson GM
    J Clin Psychiatry; 1988 Jul; 49(7):258-61. PubMed ID: 2899071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impact of dopamine supersensitivity psychosis in treatment-resistant schizophrenia: An analysis of multi-factors predicting long-term prognosis.
    Yamanaka H; Kanahara N; Suzuki T; Takase M; Moriyama T; Watanabe H; Hirata T; Asano M; Iyo M
    Schizophr Res; 2016 Feb; 170(2-3):252-8. PubMed ID: 26775264
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clozapine treatment for neuroleptic-induced tardive dyskinesia, parkinsonism, and chronic akathisia in schizophrenic patients.
    Spivak B; Mester R; Abesgaus J; Wittenberg N; Adlersberg S; Gonen N; Weizman A
    J Clin Psychiatry; 1997 Jul; 58(7):318-22. PubMed ID: 9269253
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.